skip navigation

Skip Nav

Clinical Guidelines Portal

Clinical Guidelines Portal

Guidelines for the Prevention and Treatment of Opportunistic Infections in HIV-Infected Adults and Adolescents

Appendix C: Panel Roster and Financial Disclosures

Endemic Mycoses

(Last updated:November 01, 2012; last reviewed:November 01, 2012)

Endemic Mycoses
Member Financial Disclosure
Company Relationship
Ampel, Neil*
University of Arizona None N/A
Blair, Janis
Mayo Clinic Arizona
None N/A
Hage, Chadi
Indiana University
None N/A
Hamill, Richard
Baylor College of Medicine
None N/A
Kauffman, Carol
University of Michigan and VA Ann Arbor Healthcare System
Astellas Research Support (PI)
Merck DSMB Member, Research Support
New England Research Institutes
Adjudication Panel for Resolving Infection in Neutropenia with Granulocytes Study
Pfizer Honoraria, Other, Travel Support
Pappas, Peter
University of Alabama at Birmingham
Astellas Advisory Board, Consulting, Honoraria, Research Support
Merck Advisory Board, Research Support, Speaker’s Bureau
Pfizer Advisory Board, Research Support
T-2 Diagnostics Advisory Board
Perfect, John
Duke University
Astellas Advisory Board, Consultant, Honoraria, Research Support
Enzon Advisory Board, Consultant, Honoraria, Research Support
Merck Advisory Board, Consultant, Honoraria, Research Support
Pfizer Consultant, Honoraria, Research Support
Schering-Plough
Advisory Board, Consultant, Honoraria, Research Support
*Group lead

Note: Members were asked to disclose all relationships from 24 months before the writing panel convened. The period of reporting was from June 1, 2008, through November 1, 2012.

Back to Top